Journal of Cancer Research and Therapeutics Close
 

Figure 2: (a) Immunohistochemical staining exhibiting, diffuse cytoplasmic positivity for pancytokeratin (Pan CK, ×400), (b) strong cytoplasmic positivity for cytokeratin 5/6 (CK 5/6, ×400), (c) cytoplasmic vimentin positivity (Vimentin, ×400), (d) nuclear positivity for p63 (p63, ×400)

Figure 2: (a) Immunohistochemical staining exhibiting, diffuse cytoplasmic positivity for pancytokeratin (Pan CK, ×400), (b) strong cytoplasmic positivity for cytokeratin 5/6 (CK 5/6, ×400), (c) cytoplasmic vimentin positivity (Vimentin, ×400), (d) nuclear positivity for p63 (p63, ×400)